Barclays PLC (LON:BARC – Get Free Report)’s stock price reached a new 52-week high on Thursday . The company traded as high as GBX 265.50 ($3.37) and last traded at GBX 264.95 ($3.36), with a volume of 413758094 shares changing hands. The stock had previously closed at GBX 258.95 ($3.28).
Analysts Set New Price Targets
BARC has been the subject of several recent analyst reports. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 270 ($3.42) price objective on shares of Barclays in a research note on Monday, September 9th. Citigroup reiterated a “buy” rating on shares of Barclays in a report on Monday, September 2nd. Finally, Shore Capital restated a “buy” rating on shares of Barclays in a research note on Thursday, October 24th. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of GBX 276 ($3.50).
Read Our Latest Stock Report on BARC
Barclays Stock Up 2.2 %
Insider Activity
In other Barclays news, insider Anna Cross sold 49,013 shares of the firm’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of GBX 221 ($2.80), for a total value of £108,318.73 ($137,320.91). Also, insider Brian Gilvary sold 109,404 shares of the company’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of GBX 249 ($3.16), for a total transaction of £272,415.96 ($345,354.92). Company insiders own 1.47% of the company’s stock.
Barclays Company Profile
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International division segments. It offers financial services, such as retail banking, credit cards, wholesale banking, investment banking, wealth management, and investment management services.
Featured Stories
- Five stocks we like better than Barclays
- Stock Average Calculator
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What are earnings reports?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with MarketBeat.com's FREE daily email newsletter.